Latest1 information on COVID-19
©2022 Stanford Medicine
Not Recruiting
Trial ID: NCT00482157
Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance
Professor of Medicine (Oncology) and, by courtesy, of Urology
Inclusion Criteria:- Untreated prostate adenocarcinoma by an extended biopsy (>8 needle
cores on systematic prostate biopsy) within 1 year of the screening date
- PSA <10.0 ng/ml
- Gleason sum 6 or <2 mm Gleason pattern 4
- No more than 33% of biopsy cores positive Exclusion Criteria:- Prior or concurrent
treatment for prostate cancer
- Use of Finasteride, Dutasteride, Saw Palmetto
- Use of NSAIDs, COX-2 inhibitors and/or aspirin, soy or vitamin D supplements for more
than 7 days over the one month prior to study
- Kidney disease, hypercalcemia or renal stones
- ECOG performance status >1
- Uncontrolled hypertension, unstable angina, history of transient ischemic attack
(TIA), history of stroke.
drug: Vitamin D (Calcitriol)
Not Recruiting
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Cancer Clinical Trials Office CCTO
6504987061